3 completed. 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow gadoversetamide: new trials by email Literature Review of gadoversetamide trials Research Report on gadoversetamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies regadenoson, Optimark®, Myocardial perfusion MRI - Coronary Artery Disease, CAD | Not applicable | Completed | Daniel S. Berman | 44 | 2014-05-16 | 2018-08-20 |
| Identification of Adverse Plaque Characteristics by Coronary MR Angiography Coronary MR Angiography (CMRA) - Coronary Artery Disease | Not applicable | Completed | Cedars-Sinai Medical Center | 2 | 2012-04-01 | 2021-01-27 |
| Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients MRI, Gadoversetamide - Pathological Processes | Phase 4 | Completed | Guerbet | 100 | 2002-05-01 | 2017-08-01 |
Coronary Artery Disease (2) · Pathologic Processes (1)
Cedars-Sinai Medical Center (1) · Daniel S. Berman (1) · Guerbet (1)
United States (3)
Daniel S Berman, MD (2) · Eddie Darton, MD (1)